Literature DB >> 29128475

Budesonide in Autoimmune Hepatitis: The Right Drug at the Right Time for the Right Patient.

Michael P Manns1, Elmar Jaeckel2, Richard Taubert2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29128475     DOI： 10.1016/j.cgh.2017.11.003

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN： 1542-3565            Impact factor:   11.382


× No keyword cloud information.
  5 in total

1.  Synergistic effects of Lactobacillus rhamnosus culture supernatant and bone marrow mesenchymal stem cells on the development of alcoholic steatohepatitis in mice.

Authors:  Chao Cai; Da-Zhi Chen; Li-Chao Ge; Wen-Kai Chen; Sha-Sha Ye; Wei-Wei Ye; Ying Tao; Rui Wang; Ji Li; Zhuo Lin; Xiao-Dong Wang; Lan-Man Xu; Yong-Ping Chen
Journal:  Am J Transl Res       Date:  2019-09-15       Impact factor: 4.060

2.  BUDESONIDE-INDUCED HYPEROSMOLAR HYPERGLYCEMIC STATE FOLLOWING TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT.

Authors:  Thejus Jayakrishnan; Meera Babu; Steven Goodnow; Brent Hardman
Journal:  AACE Clin Case Rep       Date:  2020-09-21

Review 3.  Natural history and management of refractory autoimmune hepatitis.

Authors:  Bridget Whitehead; Alyssa Kriegermeier
Journal:  Clin Liver Dis (Hoboken)       Date:  2022-07-22

4.  The efficacy and adverse effects of budesonide in remission induction treatment of autoimmune hepatitis: a retrospective study.

Authors:  Omer Burcak Binicier; Süleyman Günay
Journal:  Croat Med J       Date:  2019-08-31       Impact factor: 1.351

5.  Adjuvant Therapy with Budesonide Post-Kasai Reduces the Need for Liver Transplantation in Biliary Atresia.

Authors:  Joachim F Kuebler; Omid Madadi-Sanjani; Eva D Pfister; Ulrich Baumann; David Fortmann; Johannes Leonhardt; Benno M Ure; Michael P Manns; Richard Taubert; Claus Petersen
Journal:  J Clin Med       Date:  2021-12-09       Impact factor: 4.241
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.